FDA Grants Approval to Garzulys, a Rapid-Acting Insulin Biosimilar Endocrinology Advisor 17:05 Mon, 03 Aug
Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection Business Wire (Press Release) 20:09 Thu, 30 Jul
